发明名称 3,4,(5)-SUBSTITUTED TETRAHVDROPYRIDINES
摘要 <p>Organic Compounds 3,4(,5)-substituted tetrahydropyridine compounds, these compounds for use in the diagnostic and therapeutic treatment of a warm-blooded animal, especially for the treatment of a disease that depends on activity of renin; the use of a compound of that class for the preparation of a pharmaceutical formulation for the treatment of a disease that depends on activity of renin; the use of a compound of that class in the treatment of a disease that depends on activity of renin; pharmaceutical formulations comprising a 3,4(,5)- substituted tetrahydropyridine compound, and/or a method of treatment comprising administering a 3,4(,5)-substituted tetrahydropyridine compound, a method for the manufacture of a 3,4(,5)- substituted tetrahydropyridine compound, and novel intermediates and partial steps for its synthesis. The 3,4(,5)- substituted tetrahydropyridine compounds have the formula I wherein the substituents and symbols are as described in the specification.</p>
申请公布号 WO2006074924(A1) 申请公布日期 2006.07.20
申请号 WO2006EP00216 申请日期 2006.01.12
申请人 NOVARTIS AG;NOVARTIS PHARMA GMBH;MASUYA, KEIICHI;IRIE, OSAMU;NIHONYANAGI, ATSUKO;TOYAO, ATSUSHI;KANAZAWA, TAKANORI 发明人 IRIE, OSAMU;NIHONYANAGI, ATSUKO;TOYAO, ATSUSHI;KANAZAWA, TAKANORI
分类号 C07D211/78;A61K31/4545;A61P9/00;C07D401/10;C07D401/12;C07D409/12 主分类号 C07D211/78
代理机构 代理人
主权项
地址